HOB Biotech Group Corp,Ltd Financials

Market Capitalization CN¥8.13 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	234.55
Forward PE
Price to Sales TTM	CN¥20.63
Price to Book MRQ	CN¥9.86
Enterprise to Revenue	21.51
Enterprise to EBITDA	103.94

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	8.78%
Operating Margin	1.25%
Return on Assets TTM	2.58%
Return on Equity TTM	4.24%

Income Statement

Revenue TTM	CN¥394,352,192
Revenue per Share TTM	CN¥6.55
Quarterly Revenue Growth	-9.30%
Gross Profit TTM	CN¥249,040,736
EBITDA	CN¥43,558,952
Net Income to Common TTM	CN¥34,633,392
Diluted EPS TTM	CN¥0.55
Quarterly Earnings Growth YoY	-57.00%

Balance Sheet

Total Cash MRQ	CN¥94,155,296
Total Cash per Share MRQ	CN¥1.51
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	15.09
Current Ratio MRQ	1.56
Book Value per Share MRQ	CN¥13.09

Cash Flow

Operating Cash Flow TTM	CN¥97,492,192
Levered Free Cash Flow TTM	CN¥-37,764,240

688656 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	63,058,328
Float Shares	34,858,325
Avg 10 Volume	2,318,070
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	71.32%
% Held by Institutions	6.41%

Stock Price Summary

Beta	-0.61
Fifty Two Week Low	CN¥19.47
Fifty Two Week High	CN¥165.21
Fifty Two Week Change	82.13%
Day 50 MA	CN¥101.82
Day 200 MA	CN¥87.51

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.20
Forward Annual Dividend Yield	0.94%
Trailing Annual Dividend Rate	CN¥0.30
Trailing Annual Dividend Yield	0.24%
Payout Ratio	72.73%
Dividend Date
Ex Dividend Date	2025-05-29
Last Split Factor
Last Split Date